Novel Targeted Therapies in CLL Might Expand Treatment Options
Filed under: Maryland Drug Treatment Centers
"These exciting developments in CLL therapy represent a shift toward treatments that hone in on specific regulators of cancer, ultimately providing a safer and more effective treatment regimen," said Jennifer R. Brown, MD, PhD, director of the Chronic …
Read more on Medscape
Baxter Submits Application for FDA Approval of OBI-1 for Patients with …
Filed under: Maryland Drug Treatment Centers
DEERFIELD, Ill., Dec 10, 2013 (BUSINESS WIRE) — Baxter International Inc. (NYSE:BAX) today announced that the company has submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of OBI-1 …
Read more on MarketWatch
Novartis, Gilead, Genentech & More: An ASH 2013 Wrap-Up
Filed under: Maryland Drug Treatment Centers
Marchione's story describes the same CART therapy work out of Penn, makes reference to competitors at places like Memorial Sloan-Kettering Cancer Center and MD Anderson Cancer Center, and quotes a few very optimistic researchers. At the end … Gilead …
Read more on Xconomy